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Background: Exposure to microgravity or immobilization results in alterations of renal function, fluid redistribution
and bone loss, which couples to a rise of urinary calcium excretion. We recently demonstrated that high calcium
delivery to the collecting duct reduces local Aquaporin-2 (AQP2) mediated water reabsorption under vasopressin
action, thus limiting the maximal urinary concentration and reducing calcium saturation. To investigate renal water
balance adaptation during bed rest, a model to mimic the effects of microgravity on earth, the effect of changes in
urinary calcium on urinary AQP2 excretion were assessed.
Methods: Ten healthy men (aged 21-28 years) participated in the experiment. Study design included 7 days of
adaptation and 35 days of continuous bed rest (days -6 to 0 and 1 to 35, respectively) under controlled diet. Food
records and 24-hour urine samples were collected daily from day -3 to 35. Changes in blood hematocrit were used
as an indirect index of plasma volume changes. AQP2 excretion was measured by ELISA.
Results: Bed rest induced bone demineralization and a transient increase in urinary calcium followed by transient
decrease in AQP2 excretion, which can reduce the urine concentrating ability causing plasma volume reduction.
The return of calciuria to baseline was followed by a recovery of AQP2 excretion, which allows for a partial
restoration of plasma volume.
Conclusions: These results further support the view that urinary calcium can modulate the vasopressin-dependent
urine concentration through a down-regulation of AQP2 expression/trafficking. This mechanism could have a key
role in the prevention of urine super-saturation due to hypercalciuria.
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Urinary calcium saturation is an important factor in
nephrolitiasis and is strictly correlated to vasopressin-
dependent water reabsorption in the kidney. Vasopressin
signaling promotes water reabsorption in the renal col-
lecting duct by triggering redistribution of the water
channels AQP2 from intracellular vesicles into the plasma
membrane [1-3]. This permits water entry into the cell
and water exit through basolateral AQP3 and AQP4
resulting in the concentration of urine. Defects of AQP2
trafficking cause diseases such as nephrogenic diabetes* Correspondence: giovanna.valenti@uniba.it
†Equal contributors
1Department of Biosciences, Biotechnologies and Biopharmaceutics,
University of Bari Aldo Moro, Via Amendola 165/A, Bari 70126, Italy
Full list of author information is available at the end of the article
© 2014 Tamma et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.insipidus (NDI), a disorder characterized by a massive loss
of hypoosmotic urine [4]. AQP2 is partially excreted in the
urine [5] and excretion is proportional to its expression in
the kidney and in the luminal membrane of renal collect-
ing duct principal cells making a useful biomarker for
water concentration diseases [6,7]. Specifically, an increase
in AQP2 excretion is observed under vasopressin action
as a result of AQP2 activation and translocation to the
membrane whereas a reduced AQP2 excretion reflects re-
duced activation of the water channel and reduced renal
ability to conserve water. We have previously shown that
in hypercalciuric subjects the physiological response to
vasopressin is followed by a less pronounced increase in
urinary osmolality and urinary AQP2 indicating a reduced
urinary concentrating ability [8]. These data suggest that
high calcium delivery to the collecting duct reduces localLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tion limiting the maximal urinary concentration and redu-
cing calcium saturation.
Immobilization or exposure to microgravity induce
several alterations of renal function including fluid redis-
tribution and bone loss causing increased calciuria and
reduced plasma volume [9,10]. In this context, bed rest
represents a valuable experimental model to mimic the
effects of microgravity on earth [11].
In this work we evaluated the effects of the bed rest-
induced changes in urinary calcium on AQP2 excretion.
The prior hypothesis was that bed rest-induced increase
in urinary calcium should be followed by a decrease in
urinary AQP2.
Methods
Subjects and bed rest design
In 2007 a 35-day bed rest experiment was performed in
the Valdoltra Orthopedic Hospital (Ankaran, Slovenia)
as part of the OSMA project (OSteoporosis and Muscular
Atrophy), sponsored by the Italian Space Agency (Agenzia
Spaziale Italiana, ASI). The study conformed to the Declar-
ation of Helsinki, was approved by the Slovenian National
Committee for Medical Ethics at the Ministry of Health
(Republic of Slovenia), and included a written informed
consent.
Ten healthy men (ages 21-28 years) were selected for
the study after medical examinations and routine check-
up for exclusion of chronic diseases.
Participants were admitted in the hospital 1 week be-
fore for pre-bedrest tests and adaptation. During this
period, participants had to sleep in the hospital, had to
eat only the food of the hospital diet, had to undergo
the pre-bedrest tests and, for the remaining time, were
allowed to continue their habitual activities without re-
straints. Conversely, physical activity was not permitted
at any time during bed rest (from day 1 to day 35).
Adherence to the protocol was ascertained by continu-
ous video surveillance and medical supervision. Diet was
calculated by the FAO/WHO equations on the basis of
the expenditure at rest [12]. Diet was activity-adjusted
setting the total calorie intake at 1.4-time the rest expend-
iture during adaptation and 1.2-time the rest expenditure
during bed rest, respectively. The percentages of carbohy-
drates, fats, and proteins were identical in the two dietary
regimens (60%, 25%, and 15%, respectively). The bed rest
diet contained approximately 1 g of calcium, 1.3 g of phos-
phorus, and 600 IU of vitamin D per day.
24-hours urine was accurately collected in the last
4 days of the adaptation week (from day -3 to day 0) and
in all the 35 days of bed rest. Morning fasting blood sam-
ples and anthropometric data were collected before bed
rest at day 0 and weekly during bed rest at days 7, 14, 21,
28 and 35. Anthropometric data included the assessmentof body weight, fat mass and fat-free mass by bio-electric
impedance (Akern, Florence, Italy). Bone loss was assessed
by peripheral quantitative computer tomography (pQCT,
XCT 2000, Stratec Medizintechnik, Pforzheim, Germany)
2 days before bed rest (day -2) and on the last day of bed
rest (day 35) as described previously [13].
Automated biochemistry and commercially available
kits were used for measurements of several variables
with inclusion of serum total calcium, urinary calcium,
and blood hematocrit used as index of changes in plasma
volume.
Urinary AQP2 measurements by ELISA
(enzyme–linked –immunoSorbent –assay)
Urinary AQP2 excretion was measured in the 24-hour
urine samples by ELISA as previously described [8].
Approximately 3% of the vasopressin regulated water
channel AQP2 expressed in renal collecting duct princi-
pal cells is excreted into urine through exosomes, small
vesicles (40–80 nm) secreted into the urine by renal
epithelial cells. Exosomes remain in the supernatant at
standard centrifugation speeds providing an explanation
for the finding that AQP2, an integral membrane pro-
tein, is plentiful in urines and its excretion increases in
response to vasopressin. Briefly, urine samples were
spun at 3,000 rpm for 10 min at 4°C to remove cellular
debris in the presence of the following protease inhibi-
tors: 2 mM phenylmethylsulfonyl fluoride, 1 mg/ml leu-
peptin, 1 mg/ml pepstatin. 5 μl of urine sample were
diluted to 50 μl in PBS containing 0.01% SDS, placed
in a MaxiSorp 96-well microplate (www.nuncbrand.com)
and incubated for 16 hours at 4°C. In parallel wells, in-
creasing concentrations (50, 100, 200, 300, 400, 500
and 1,000 pg/50 μl) of a synthetic peptide reproducing
the last 15 amino acids of the C-terminal region of hu-
man AQP2 were incubated as internal standard. Each
sample was analyzed in triplicate. Wells were washed
with washing buffer (PBS-0.1% Tween20) and incubated
with a blocking solution of PBS containing 3% BSA at
room temperature for 1 hour. 10 μg of affinity-purified
anti-AQP2 antibodies were diluted in blocking solution
(final antibody dilution 1:1,000) and 50 μl of the solu-
tion was added to each well and incubated for 3 hours
at 37°C. Wells were then washed with washing buffer
and anti-rabbit IgG conjugated with horseradish perox-
idase (www.sigmaaldrich.com) was added to each well
and incubated for 1 hour at 37°C. After five washings
with washing buffer, 50 μl of the substrate solution [2,29-
azino-bis(3-ethylbenzthiazoline-6-sulfonic acid); www.
sigmaaldrich.com] were added to each well and incubated
for 30 minutes in the dark. Absorbance was measured
with a microplate reader (Model 550, www.bio-rad.com)
at 405 nm. Urinary AQP2 excretion was expressed as
fmol/mg urine creatinine.
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The analysis was based on intra-individual comparisons
between data at given days of bed rest and pre-bed rest
data, from here-on defined as baseline. For urinary cal-
cium, baseline was defined as the mean of 24-hours
urinary excretion in the last four days of adaptation
(days -3, -2, -1, and 0 respectively). For plasma variables,
baseline was defined as the value at day 0. For AQP2 ex-
cretion baseline was the value measured at day 0. The
significance of the bed rest effects was assessed by com-
parison of bed rest data to baseline by paired t-test.
Results
In this study we evaluated the effect of the increase in
urinary calcium associated with prolonged bed rest, on
excretion of the AQP2 water channel, a biomarker for
collecting duct responsiveness to vasopressin.
Ten healthy men (aged 21-28 years) participated in the
experiment in the Hospital of Ankaran (Slovenia). Food
records and 24-hours urine samples were collected daily
from day -3 to 35. Under these conditions, previous
studies showed that bed rest induces bone deminer-
alization and transient increase in urinary calcium [13,14].
Changes in blood hematocrit were used as indirect index
of plasma volume changes.
Urine volume decreased after the switch from adapta-
tion diet to bed rest diet but did not significantly change
during bed rest (upper left panel of Figure 1). Bed rest
was associated with an increase in blood hematocrit with
a transient peak at day 7 and a later stable plateau (lower
left panel of Figure 1) indicating a plasma volume contrac-
tion. Bed rest associated initially with parallel increases in
serum and urinary calcium and later with a slow decline
below baseline for serum calcium and toward baseline for
urinary calcium (right panels of Figure 1).
Parathyroid hormone (PTH) progressively declined
during bedrest reaching a significantly lower value at
day 35 with respect to day 0 (29.6 ± 3.6 pg/mL at day 0 vs
14.8 ± 2.1 pg/mL at day 35, P < 0.001). The sustained
downregulation of the PTH during immobilization was
not due to high calcemia which disappeared after day 14
(Figure 1).
Evaluation of urinary AQP2 excretion is shown in
Figure 2. No significant changes in AQP2 excretion during
the first 7 days of bed rest were observed (626 ± 14 fmol/
ml and 645 ± 7 fmol/ml at day 0 and day 7 respectively).
After the seventh day, however, a significant progressive
decrease in AQP2 excretion was measured reaching the
lowest value at day 14 (569 ± 10 fmol/ml, P < 0.05 vs day
0) followed by a progressive slow recovery. AQP2
remained, however, below baseline values until days
20-22 (608 ± 10 fmol/ml at day 21) (Figure 2). Interest-
ingly, the observed reduction in AQP2 excretion coin-
cided with the transient increase in calciuria in the samegiven time period, followed by stabilization to baseline
values around day 28 (Figures 1 and 2). AQP2 excretion
at day 35 that is after return of calciuria to baseline
was significantly higher than baseline (702 ± 27 fmol/ml,
P < 0.05 vs day 0). This increase could reflect late adapta-
tion secondary to plasma volume reduction.
Discussion
Bed rest represents a good model of simulated micro-
gravity on earth. Previous studies showed that bed rest
induces several alterations of physiological parameters
including the increase in blood hematocrit due to hemo-
concentration and high urinary calcium secondary to
bone demineralization [13,14]. The increase in blood
hematocrit due to hemoconcentration may reflect water
loss associated with a reduction of AQP2-mediated
water reabsorption as a consequence of the increase in
urinary calcium. Previous evidence supports the notion
that this physiological adaptation is due to a complex
interplay between AQP2 and the Calcium Sensing Recep-
tor (CaSR) expressed in the luminal membrane of renal
collecting duct principal cells [6,8,15-17]. Specifically,
during vasopressin action, an increase in urinary calcium
concentration would activate the CaSR, which in turn at-
tenuates AQP2-mediated water reabsorption and urinary
concentration in humans [8]. This complex mechanism
may represent an internal renal defense to mitigate the
effects of hypercalciuria on the risk of calcium precipita-
tion during antidiuresis.
The present study would favor this concept demon-
strating that bed rest induces a biphasic response in
AQP2 excretion. The early phase of bed rest from day 7
to day 14 was associated with a transient significant de-
crease in AQP2 excretion, which is likely secondary to
the hypercalciuric response. This down-regulation of
AQP2 excretion could reduce the urine concentrating
ability and, via this effect, could contribute to hemocon-
centration due to a reduction of plasma volume and
consequent increase in hematocrit. In a later phase, the
decline of calciuria toward baseline is followed by a re-
covery of AQP2 excretion, which increases to values
significantly higher than baseline at day 35. This late
increase in AQP2 could reflect the combination of an in-
creased vasopressin secretion due to plasma volume re-
duction with near-normal levels of urinary calcium.
Together these data represent the first detailed analysis
of the inverse modulation of AQP2 excretion correlated
with the transient increase in calciuria during a pro-
longed bed rest, mimicking chronic adaptation to micro-
gravity. A previous study evaluated AQP2 excretion
during thermoneutral water immersion (6 hours water
immersion), another ground-based analog of microgravity
that mimicks, however, acute adaptation to microgravity.
Water immersion resulted in a significant increase in
Figure 2 Mean ± SE of AQP2 excretion during 35 days bed rest. AQP2 excretion, expressed in fmol/ml, was measured by ELISA in 24 hours
urine samples. Statistical analysis was done using paired t-test (*P < 0.05).
Figure 1 Time course of urine volume (mL/24 h), serum total calcium (mmol/L), hematocrit (%), urinary calcium (mmol/24 h) during
35 days continuous bed rest. Data are expressed as mean ± SE. Statistical analysis was done using paired t-test (***P < 0.001, **P < 0.01, *P < 0.05).
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AQP2 alteration and mainly due to reduced vasopressin
secretion [18].
Altogether, our data demonstrate that chronic adap-
tation to microgravity simulated by prolonged bed rest
induces a transient increase in urinary calcium and mod-
ulates AQP2 excretion due to the inhibition of AQP2
insertion into the plasma membrane during vasopressin
action. A complete recovery of AQP2 excretion is, on
the other hand, associated to return of calciuria to
normal values.
Conclusions
In conclusion, we report here that prolonged bed rest
induces bone demineralization and transient increase in
urinary calcium followed by a transient decrease in
AQP2 excretion, which can reduce the ability to concen-
trate urine ability causing plasma volume reduction. The
return of calciuria to baseline is followed by a recovery of
AQP2 excretion, which allows for a partial restoration of
plasma volume. These results further support the view that
urinary calcium can modulate the vasopressin-dependent
urine concentration through a down-regulation of AQP2
expression/trafficking. This mechanism could have a key
role in the prevention of urine super-saturation due to
hypercalciuria.
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